Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 11, 2019

SELL
$48.76 - $63.23 $292,560 - $379,380
-6,000 Closed
0 $0
Q2 2018

Jul 23, 2018

BUY
$50.53 - $62.98 $101,060 - $125,960
2,000 Added 50.0%
6,000 $332,000
Q3 2017

Oct 16, 2017

BUY
$55.23 - $63.74 $220,920 - $254,960
4,000
4,000 $255,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Chickasaw Capital Management LLC Portfolio

Follow Chickasaw Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chickasaw Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chickasaw Capital Management LLC with notifications on news.